BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 3857775)

  • 1. Cyclosporin A in the treatment of posterior uveitis.
    Graham EM; Sanders MD; James DG; Hamblin A; Kasp Grochowska E; Dumonde D
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():146-51. PubMed ID: 3857775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions].
    Sakane T; Mochizuki M; Inaba G; Masuda K
    Ryumachi; 1995 Oct; 35(5):802-13. PubMed ID: 8594659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of noninfectious posterior uveitis with a new immunomodulator, cyclosporin A: initial results].
    Le Hoang P; Fontaine M; Khalaf A; Travers C; Saraux H; Coscas G; Massin M; Bernard JA; Gaudric A; de Kozak Y
    Bull Soc Ophtalmol Fr; 1985; 85(8-9):873-6. PubMed ID: 3836786
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of the ocular form of Behçet disease with cyclosporin A].
    Pahlitzsch T; Wyrobisch W; Kämpe C; Wiederholt M
    Klin Monbl Augenheilkd; 1990 Jun; 196(6):466-9. PubMed ID: 2376943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of refractory posterior uveitis with anti-TNFalpha (infliximab).
    Benitez-del-Castillo JM; Martinez-de-la-Casa JM; Pato-Cour E; Méndez-Fernández R; López-Abad C; Matilla M; Garcia-Sanchez J
    Eye (Lond); 2005 Aug; 19(8):841-5. PubMed ID: 15389273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cyclosporin A in the treatment of uveitis in Behçet's disease: apropos of a case].
    Annonier P; Brini A
    Bull Soc Ophtalmol Fr; 1986 Mar; 86(3):305-8. PubMed ID: 3802341
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of intraocular inflammatory disease with cyclosporin A.
    Nussenblatt RB; Palestine AG; Rook AH; Scher I; Wacker WB; Gery I
    Lancet; 1983 Jul; 2(8344):235-8. PubMed ID: 6135075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects.
    Tognon S; Graziani G; Marcolongo R
    Ann N Y Acad Sci; 2007 Sep; 1110():474-84. PubMed ID: 17911463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cyclosporin treatment in uveitis].
    Quentin CD; Vogel M
    Klin Monbl Augenheilkd; 1986 Mar; 188(3):248-50. PubMed ID: 3713099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveitis in Behçet disease: an analysis of 880 patients.
    Tugal-Tutkun I; Onal S; Altan-Yaycioglu R; Huseyin Altunbas H; Urgancioglu M
    Am J Ophthalmol; 2004 Sep; 138(3):373-80. PubMed ID: 15364218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: an open-label trial.
    Tugal-Tutkun I; Mudun A; Urgancioglu M; Kamali S; Kasapoglu E; Inanc M; Gül A
    Arthritis Rheum; 2005 Aug; 52(8):2478-84. PubMed ID: 16052571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine in Behçet's disease resistant to conventional therapy.
    Caspers-Velu LE; Decaux G; Libert J
    Ann Ophthalmol; 1989 Mar; 21(3):111-6, 118. PubMed ID: 2735696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behçet's disease: a study of 20 cases].
    Jacobs K; Vrijghem JC; Linsen C; Leys A
    Bull Soc Belge Ophtalmol; 1989; 230():85-93. PubMed ID: 2488438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study.
    Gül A; Tugal-Tutkun I; Dinarello CA; Reznikov L; Esen BA; Mirza A; Scannon P; Solinger A
    Ann Rheum Dis; 2012 Apr; 71(4):563-6. PubMed ID: 22084392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severe uveitis with cyclosporin A].
    Harada T; Sugita K; Saito A; Awaya S
    Ophthalmologica; 1987; 195(1):21-5. PubMed ID: 3658332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab in the treatment of refractory posterior uveitis.
    Joseph A; Raj D; Dua HS; Powell PT; Lanyon PC; Powell RJ
    Ophthalmology; 2003 Jul; 110(7):1449-53. PubMed ID: 12867408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A in the treatment of severe Behçet's uveitis.
    Binder AI; Graham EM; Sanders MD; Dinning W; James DG; Denman AM
    Br J Rheumatol; 1987 Aug; 26(4):285-91. PubMed ID: 3300835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of cyclosporin-a in the treatment of Behçet's disease.
    Atmaca LS; Batioğlu F
    Ophthalmic Surg; 1994 May; 25(5):321-7. PubMed ID: 8058265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does lowering hyperhomocysteinemia by folic acid beneficial for oculo-Behcet's disease? A pilot study.
    Houman MH; Naffati H; Khanfir M; Ghannouchi M; Ben Ghorbel I; Lamloum M; El Matri L; Hamzaoui K; Jeddi A; Miled M; Fki M
    Tunis Med; 2007 Jun; 85(6):450-3. PubMed ID: 17644895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.